Updated: January 28, 2026
How to Help Your Patients Save Money on Rivastigmine: A Provider's Guide to Savings Programs
Author
Peter Daggett

Summarize with AI
- Understanding Rivastigmine's Cost Landscape
- Insurance and Medicare Part D: What Prescribers Need to Know
- Strategy 1: Prescribe Generic Rivastigmine by Default
- Strategy 2: Recommend Coupon Programs to Appropriate Patients
- Strategy 3: Route Patients to Mail-Order for 90-Day Supplies
- Strategy 4: Low-Income and Uninsured Patient Resources
- Strategy 5: Consider Switching to Capsule If Patch Cost Is a Barrier
- Helping Patients Locate and Afford Rivastigmine
A provider-focused guide to helping dementia patients reduce out-of-pocket costs on rivastigmine — insurance tiers, coupon programs, mail-order, and low-income assistance.
For patients with Alzheimer's or Parkinson's disease dementia, cost is a real barrier to consistent medication adherence. This is especially true for patients on fixed incomes, those using Medicare with gap coverage issues, or uninsured patients. This provider-focused guide outlines the most effective cost-reduction strategies for rivastigmine in 2026 — from formulary management to patient assistance resources.
Understanding Rivastigmine's Cost Landscape
The cost of rivastigmine varies significantly by formulation:
Generic rivastigmine capsules: Retail $18–$50 per 30-day supply; as low as $12 with GoodRx. Generally affordable and not a major barrier for insured patients.
Generic rivastigmine patch: Retail $163–$424 per 30 patches; as low as $50–$100 with GoodRx or SingleCare. A meaningful cost for uninsured patients on fixed incomes.
Brand Exelon Patch: Retail $677–$823 per 30 patches. Always prescribe the generic unless there's a specific clinical reason for brand.
Insurance and Medicare Part D: What Prescribers Need to Know
Generic rivastigmine is covered on most Medicare Part D and commercial formularies. Key provider considerations:
Formulary tier: Generic rivastigmine is typically Tier 2 on most formularies. Patient copay is generally $10–$30 for a 30-day supply. The brand patch may be on a higher tier or require prior authorization.
Medicare Part D 2026 changes: The annual out-of-pocket cap for Part D is $2,100 in 2026. This protects patients who need high-dose patches from catastrophic drug costs.
Prior authorization: The brand Exelon Patch may require prior authorization or step therapy (requiring a generic trial first). Always check the patient's specific plan formulary before writing for the brand.
Preferred pharmacy networks: Advise patients to use their plan's preferred pharmacy for the lowest copay. This information is on their insurance card or available through their insurer's website.
Strategy 1: Prescribe Generic Rivastigmine by Default
The brand-name Exelon capsule has been discontinued. For the patch, prescribe "rivastigmine transdermal patch [strength] mg/24h — generic acceptable" rather than specifically requesting "Exelon Patch" unless there is a specific documented clinical need. This simple step can save patients hundreds of dollars per month.
Strategy 2: Recommend Coupon Programs to Appropriate Patients
For uninsured patients or those whose insurance copay is higher than cash-pay coupon prices, discount programs can dramatically reduce costs:
GoodRx (goodrx.com): Generic rivastigmine capsule as low as $12; generic patch as low as $50.
SingleCare (singlecare.com): Similar coupon pricing; worth comparing.
Important: Coupon cards cannot be used with Medicare or Medicaid. They are only appropriate for uninsured patients or those paying cash even with insurance.
Strategy 3: Route Patients to Mail-Order for 90-Day Supplies
For patients on a stable maintenance dose, writing for a 90-day mail-order supply:
Typically reduces per-dose cost under most commercial and Medicare plans (often equivalent to 2 copays for 3 months' supply)
Reduces the burden on caregivers of monthly pharmacy trips
Provides more consistent medication availability than relying on retail pharmacy stock
Note: a separate 90-day supply prescription is typically required. Most plans do not allow a 30-day prescription to be filled for 90 days.
Strategy 4: Low-Income and Uninsured Patient Resources
For patients without insurance or with very limited income:
Rx Outreach: A nonprofit mail-order pharmacy offering significantly reduced drug prices with free delivery. Available in all 50 states. Website: rxoutreach.org.
Medicare Extra Help (Low Income Subsidy): Eligible Medicare patients can apply for the Extra Help program, which reduces Part D premiums, deductibles, and copays. Contact the Social Security Administration at ssa.gov.
State pharmaceutical assistance programs: Many states offer programs for low-income seniors. Refer patients to their State Health Insurance Assistance Program (SHIP) or state department of aging.
NeedyMeds.org: A searchable database of patient assistance programs, disease-specific programs, and free clinic resources.
Strategy 5: Consider Switching to Capsule If Patch Cost Is a Barrier
When cost is a primary driver and the patch formulation is too expensive, consider whether the patient could tolerate the oral capsule. The capsule is significantly cheaper and equally effective — the main downsides are twice-daily dosing and a higher likelihood of GI side effects. For patients without significant GI sensitivity, this tradeoff may be reasonable.
Helping Patients Locate and Afford Rivastigmine
For patients struggling with both availability and cost, medfinder.com/providers can help locate which pharmacies near the patient have rivastigmine in stock. For a patient-friendly version of this savings guide, refer them to our rivastigmine savings guide for patients.
Frequently Asked Questions
Yes. Generic rivastigmine transdermal patches are covered under Medicare Part D. The brand Exelon Patch may require prior authorization or step therapy on some plans. In 2026, the Medicare Part D annual out-of-pocket cap is $2,100. For low-income patients, the Extra Help program can significantly reduce Part D costs.
No manufacturer patient assistance program (PAP) is currently available for generic rivastigmine as of 2026. For low-income uninsured patients, Rx Outreach (rxoutreach.org) provides significantly reduced prices with free delivery. Medicare recipients may qualify for the Extra Help Low Income Subsidy through the Social Security Administration.
GoodRx and other discount drug coupons cannot be used in combination with Medicare or Medicaid. Patients paying with Medicare Part D cannot use GoodRx simultaneously. However, patients can choose to pay cash with a GoodRx coupon instead of using Medicare if the coupon price is lower — this counts as an out-of-pocket expense and does not count toward their Medicare deductible.
The exact copay depends on the specific Medicare Part D plan and formulary tier. Generic rivastigmine is typically Tier 2, with copays of $10-$30 per month after the deductible is met. For the rivastigmine patch, copays may be higher. Patients should check their Annual Notice of Change (ANOC) each year for any tier or copay changes.
Write 'rivastigmine transdermal patch [strength] mg/24h — generic substitution permitted' rather than writing 'Exelon Patch.' This allows the pharmacist to dispense any FDA-approved generic version, which is typically 70-90% cheaper than the brand-name product.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Rivastigmine also looked for:
More about Rivastigmine
30,305 have already found their meds with Medfinder.
Start your search today.





